Oribel Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.3M Buy
+25,100
New +$5.41M 0.23% 101
2025
Q4
Sell
-377,100
Closed -$59.2M 115
2025
Q3
$59.2M Buy
377,100
+30,000
+9% +$4.63M 1.86% 17
2025
Q2
$58.3M Sell
347,100
-484,500
-58% -$71.9M 1.49% 19
2025
Q1
$115M Buy
831,600
+404,900
+95% +$51.6M 4.69% 2
2024
Q4
$50.5M Buy
+426,700
New +$49.8M 1.72% 21
2023
Q2
Sell
-200,300
Closed -$15.1M 78
2023
Q1
$15.1M Buy
+200,300
New +$15.1M 1.35% 29

Other funds holding CAH

Oribel Capital Management's CAH Position: Q1 2026 in Review

Oribel Capital Management opened a new position in Cardinal Health (CAH) in Q1 2026: 25,100 shares worth $5.3M. The stake represents 0.23% of the portfolio and ranks #100 among its holdings. This is a return to the name: Oribel Capital Management previously reported a position in CAH as recently as Q3 2025.

Oribel Capital Management first reported a position in CAH in Q1 2023 and has held it in 6 quarters since. The position peaked at $115M in Q1 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Oribel Capital Management held 25,100 shares of Cardinal Health worth $5.3M as of Q1 2026.
  • Cardinal Health was a new Oribel Capital Management position in Q1 2026.
  • Cardinal Health made up 0.23% of Oribel Capital Management's portfolio in Q1 2026, its #100 holding.
  • Oribel Capital Management first reported a position in Cardinal Health in Q1 2023 and has held it in 6 quarters since.
  • Oribel Capital Management's Cardinal Health position peaked at $115M in Q1 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Oribel Capital Management's 13F filing for Q1 2026, filed 14 May 2026.